Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Maintain BUY on Capacite Infraprojects - Marginal miss - HDFC Securities

Posted On: 2021-06-15 16:44:18 (Time Zone: UTC)


Mr. Parikshit D Kandpal, CFA, HDFC Securities and Mr. Chintan Parikh, Institutional Research Analyst, HDFC Securities

Capacite Infraprojects Ltd. (CIL) missed our revenue/EBITDA/APAT estimates by 5/4/7% as lockdown following the second wave of the pandemic affected execution during Mar-21. Labour availability, which had fallen by 40% in May, is expected to normalise by the end of June-21. Management has guided for INR 20bn of topline/order inflow for FY22. CIL could also expand into the international market if the client fits in its quality framework. Given that large part of order book of INR 87bn has raw material inflation pass-through, margins are expected to remain resilient at 16.5%, despite the sharp rise in commodity prices. With execution ramping up and share of government orders increasing, CIL is well placed for a rerating. We cut our FY22E/23E est. by 33/6% to account for the impact of the second wave and maintain BUY with reduced target price of INR 300/sh (vs INR 320/sh earlier).

4QFY21 financial highlights: Revenue: INR 3.7bn (+20%/+21% YoY/QoQ, 5% miss). EBITDA: INR 664mn (+39% YoY, +22% QoQ, 4% miss). EBITDA margin: 18.0% (+249/+14 bps YoY/QoQ, vs est. of 17.7%). Interest cost came in at INR 190mn (+3% YoY, +9% QoQ, vs INR 180mn est.). Other income of INR 121mn (2.1x/2.3x 4QFY20/3QFY21) includes INR 90mn reversal of ECL provisions. APAT: Rs 244mn (6.4x 4QFY20, +60% QoQ, 7.5% miss).

INR 20bn topline/order inflow guidance: CIL has guided for INR 20bn of revenue in FY22 as it looks to ramp up execution in CIDCO project (we expect ~INR 6.5bn contribution for FY22). However, we remain cautious and build in INR 18.5bn revenue for FY22. Order inflow was tepid at INR 1.5bn in FY21 as CIL focused on execution of INR 105bn of the OB (Mar-20). On the back of strong tailwinds in residential real estate and healthcare sectors, CIL is targeting INR 20bn inflow in FY22, which is conservative, in our view. Management has identified INR 430bn of prospective orders, of which it may bid for ~INR 230bn (INR 121bn for healthcare and INR 114bn for private/public).

NWC normalisation by Dec-21: Standalone net debt increased to INR 2.4bn (net D/E 0.26x) from INR 2bn (net D/E 0.22x) at FY20-end. NWC days also increased to 158 days from 98 in FY20 due to lower denominator. CIL expects working capital to normalise by Dec-21 as it ramps up execution and focuses on collection. FY22-23 Capex is pegged at INR 750-800mn.

Shares of Capacite Infraprojects Ltd was last trading in BSE at Rs.209.9 as compared to the previous close of Rs. 209.4. The total number of shares traded during the day was 37408 in over 1688 trades.

The stock hit an intraday high of Rs. 216.4 and intraday low of 209.15. The net turnover during the day was Rs. 7956182.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Maintain BUY on Gateway Distriparks - Upbeat outlook with expected commencement of DFC - HDFC Securities

Maintain ADD on Colgate Palmolive - Steady growth, buoyant margins - HDFC Securities

Ajanta Pharma - Downgraded to ADD - India shines, margins a tad lower - HDFC Securities

Maintain REDUCE on ABB India - Capex recovery awaited - HDFC Securities

Tech Mahindra - Healthy deal wins - HDFC Securities

SRF Ltd - Technical textiles garners high realisation - HDFC Securities

UTI Asset Management Company - Tailwinds galore! - HDFC Securities

Sagar Cements - Strong show; capacity set to increase 43% in Sep-21 - HDFC Securities

Maintain ADD on Radico Khaitan - Beat in volumes, remain constructive - HDFC Securities

Mahindra Lifespaces - Mixed performance - HDFC Securities

Indus Towers - Q1 FY22 first cut - YES Securities

Tech Mahindra - Q1 FY22 first cut - YES Securities

TVSL - Q1 FY22 first cut - YES Securities

Orient Electric - Q1 FY22 first cut - YES Securities

Security and Intelligence Services (SIS) - Q1FY22 Concall Highlights - YES Securities

LIC Housing - Q1 FY22 first cut - YES Securities

Home First - Q1 FY22 first cut - YES Securities

Colgate-Palmolive (India) - Q1 FY22 Result Report - YES Securities

Ajanta Pharma - Q1 FY22 Result Report - YES Securities

Sagar Cements Ltd - Q1 FY22 Result Report - YES Securities

CCL Products (India) - Q1 FY22 Result Report - YES Securities

UTI AMC - Q1 FY22 Result Report - YES Securities

Dalmia Bharat Ltd - Q1 FY22 Result Report - YES Securities

Mahanagar Gas Ltd - Q1 FY22 Result Report - YES Securities

Dwarikesh Sugar - Q1FY22 First Cut - ICICI Direct

Tech Mahindra - Q1FY22 First Cut - ICICI Direct

PVR Ltd - Q1FY22 First Cut - ICICI Direct

EPL Ltd - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - TCI Express - ICICI Direct

Q1FY22 Result Update - Sagar Cements - ICICI Direct

Solar Industries - Q1FY22 First Cut - ICICI Direct

Indus Towers (erstwhile Bharti Infratel) - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Mahindra Logistics - ICICI Direct

Q1FY22 Result Update - Maruti Suzuki - ICICI Direct

Q1FY22 Result Update - Mold-Tek Packaging - ICICI Direct

Q1FY22 Result Update - Nestlé India - ICICI Direct

Q1FY22 Result Update - Coforge Ltd - ICICI Direct

Q1FY22 Company Update - Birlasoft Ltd - ICICI Direct

Colgate Palmolive - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Granules India - ICICI Direct

Q1FY22 Company Update - Pfizer Ltd - ICICI Direct

Jyothy Lab - Q1FY22 First Cut - ICICI Direct

Dalmia Bharat - Strong performance; embarks on major expansion - HDFC Securities

Maintain BUY on Teamlease Services - Future bright - HDFC Securities

Maintain REDUCE on Nestle India - Beat on revenue, a miss in margin - YES Securities

Tech Mahindra Q1FY22RU - First cut - YES SECURITIES

Maruti Suzuki - A weak quarter, CNG variants to ramp up in Q2FY22 - HDFC Securities

Taro Q1 FY22 result - key highlights - YES Securities

Tata Coffee - 1Q results - YES Securities

MSIL - Q1 FY22 results - YES Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020